Holding(s) in Company
NLC Ventures Netherlands B.V. has acquired a significant stake in Thalia Therapeutics PLC, crossing a notification threshold on July 20, 2026. The company now holds 14.47% of the voting rights, representing 256,893,337 ordinary shares. This marks a substantial increase from their previous holding of 0.00%.
Select text to share a quote on X · sign in to keep highlights & notes in your THAT notes
Non-UK issuer
- Reason for the notification (please mark the appropriate box or boxes with an "X")
| An acquisition or disposal of voting rights | X |
An acquisition or disposal of financial instruments
An event changing the breakdown of voting rights
Other (please specify) iii :
Details of person subject to the notification obligation iv
| Name | NLC Ventures Netherlands B.V. |
| City and country of registered office (if applicable) | Amsterdam, Netherlands |
Full name of shareholder(s) (if different from 3.) v
Name
City and country of registered office (if applicable)
| 5. Date on which the threshold was crossed or reached vi : | 20 July 2026 |
| 6. Date on which issuer notified (DD/MM/YYYY): | 21 July 2026 |
- Total positions of person(s) subject to the notification obligation
| Resulting situation on the date on which threshold was crossed or reached | 14.47% | 14.47% | 256,893,337 |
| Position of previous notification (if applicable) | 0.00% | 0.00% | 0 |
| A: Voting rights attached to shares | |||
| Class/type of shares ISIN code (if possible) | Number of voting rights ix | % of voting rights | |
| Direct (DTR5.1) | Indirect (DTR5.2.1) | Direct (DTR5.1) | Indirect (DTR5.2.1) |
| Ordinary shares of 0.4p (GB00BYW8QM32) | 256,893,337 | 14.47% | |
| SUBTOTAL 8. A | 256,893,337 | 14.47% | |
B 1: Financial Instruments according to DTR5.3.1R (1) (a)
SUBTOTAL 8. B 1
B 2: Financial Instruments with similar economic effect according to DTR5.3.1R (1) (b)
SUBTOTAL 8.B.2
In case of proxy voting, please identify:
Name of the proxy holder
The number and % of voting rights held
The date until which the voting rights will be held
Additional information xvi
| Place of completion | London, AIM Market |
| Date of completion | 20 July 2026 |
Notes
Name of ultimate controlling person A (chain 1)
Name of controlled undertaking B
Name of controlled undertaking C
Name of ultimate controlling person A (chain 2)
Name of controlled undertaking B
Name of controlled undertaking D
Name of ultimate controlling person A (chain3)
Name of controlled undertaking E
Name of controlled undertaking F
xvi Example: Correction of a previous notification.
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.